Abstract
A radiosynthetic method to prepare the nicotinic acetylcholine receptor radioligand (S)-5-[123I]iodo-3-(2-azetidinylmethoxy)pyridine, 5-1A, has been developed. The two-step sequence produced [123I]-5-1A in high radiochemical yield (52%), high radiochemical purity (98%), and high specific radioactivities (>8,500 mCi/μmol). Preliminary single photon emission computed tomography studies with [123I]-5-1A in baboon demonstrated the appropriate regional localization for a high-affinity nicotinic radioprobe (thalamus > frontal cortex > cerebellum). Pretreatment with cytisine blocked [123I]-5-1A uptake in all brain regions (78-59% reduction), demonstrating the specificity of the radiotracer.
Original language | English (US) |
---|---|
Pages (from-to) | 201-207 |
Number of pages | 7 |
Journal | Nuclear Medicine and Biology |
Volume | 26 |
Issue number | 2 |
DOIs | |
State | Published - Feb 1999 |
Externally published | Yes |
Keywords
- Iodine-123
- Nicotinic acetylcholine receptor
- SPECT
ASJC Scopus subject areas
- Molecular Medicine
- Radiology Nuclear Medicine and imaging
- Cancer Research